Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene shares sink after another PhIII lymphoma flop and J&J steps up for the late-stage BCMA race
Celgene shares sink after another PhIII lymphoma flop and J&J steps up for the late-stage BCMA race
Celgene shares sink after another PhIII lymphoma flop and J&J steps up for the late-stage BCMA race
Submitted by
admin
on December 23, 2017 - 12:04pm
Source:
Endpoints
News Tags:
Celgene
JNJ
clinical trials
Revlimid
follicular lymphoma
Headline:
Celgene shares sink after another PhIII lymphoma flop and J&J steps up for the late-stage BCMA race
Do Not Allow Advertisers to Use My Personal information
